Organization | University of Hawaii

University of Hawaii Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Honolulu HI United States (1907)

Organization Overview

First Clinical Trial

2001

NCT00033878

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Beau Nakamoto | Hawaii AIDS Clinical Research Program, University of Hawaii School of Medicine | Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawaii | University of Hawaii | University of Hawaii at Manoa | University of Hawaii at Manoa John A Burns School of Medicine | University of Hawaii at Manoa, John A. Burns School of Medicine, Dept. of Complementary and Alternative Medicine | University of Hawaii at Manoa, John A. Burns School of Medicine, Dept. of Complementary and Alternative Medicine and Dept. of Geriatric Medicine | University of Hawaii Cancer Research Center | University of Hawaii, Hawaii AIDS Clinical Research Program, Leahi Hospital | University of Hawaii - Hawaii Center for AIDS | University of Hawaii - Hawaii Center for AIDS (HICFA) | University of Hawaii, Hawaii Center for AIDS, John A Burns School of Medicine | University of Hawaii- Honolulu | University of Hawaii John A. Burns School of Medicine Department of Obstetrics and Gynecology | University of Hawaii, Oxford University Clinical Research Unit

Active Ingredients

Drugs in Phase 4 Trials (8)

cobicistat (stribild) (1 trial)

efavirenz (sustiva) (2 trials)

emtricitabine (emtriva) (2 trials)

lamivudine (epivir) (2 trials)

pregabalin (lyrica) (1 trial)

raltegravir (isentress) (1 trial)

tenofovir (viread) (2 trials)

zidovudine (retrovir) (2 trials)

Drugs in Phase 3 Trials (7)

maraviroc (selzentry) (2 trials)

metformin (glucophage) (1 trial)

nevirapine (viramune) (1 trial)

rosuvastatin (crestor) (1 trial)

sitagliptin (januvia) (2 trials)

soybean (1 trial)

stavudine (zerit) (1 trial)

Drugs in Phase 2 Trials (16)

cenicriviroc (1 trial)

dostarlimab (Jemperli) (1 trial)

eflornithine (ornidyl) (2 trials)

ethinyl estradiol (Estinyl) (1 trial)

everolimus (zortress) (2 trials)

ferumoxytol (feraheme) (2 trials)

fluoromethylcholine (18f) (FCH) (1 trial)

gemcitabine (gemzar) (2 trials)

lopinavir (Kaletra) (1 trial)

noni extract (2 trials)

norelgestromin (Evra) (1 trial)

norethindrone (1 trial)

oxaliplatin (eloxatin) (1 trial)

ritonavir (Norvir) (1 trial)

telmisartan (micardis) (3 trials)

tsr-022 (1 trial)

Drugs in Phase 1 Trials (7)

90-yttrium (1 trial)

atezolizumab (Tecentriq) (1 trial)

etoposide (vepesid) (1 trial)

sipuleucel-t (Provenge) (1 trial)

sodium chlorite (1 trial)

sorafenib (nexavar) (1 trial)

Drugs in Other Trials (15)

abiraterone (zytiga) (1 trial)

acetylcarnitine (1 trial)

aminolevulinic acid (levulan) (1 trial)

denosumab (prolia) (1 trial)

doxycycline (vibramycin) (1 trial)

enzalutamide (xtandi) (1 trial)

ezetimibe (zetia) (1 trial)

fentanyl (Innovar) (1 trial)

lidocaine (xylocaine) (2 trials)

niacin (1 trial)

oryza sativa (1 trial)

oxytocin (syntocinon) (1 trial)

prednisone (meticorten) (1 trial)

sodium bicarbonate (1 trial)

tranexamic acid (cyklokapron) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acquired Immunodeficiency Syndrome (Phase 3)

Acute Pain (Phase 4)

AIDS Dementia Complex (Phase 3)

Alzheimer Disease (Phase 1)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma in Situ (Phase 2)

Cardiovascular Diseases (Phase 3)

Communicable Diseases (Phase 1)

Coronary Artery Disease (Phase 2)

Dementia (Phase 3)

Diabetes Mellitus (Phase 3)

Hepatitis (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

HIV Infections (Phase 3)

Immunologic Deficiency Syndromes (Phase 2)

Infections (Phase 1)

Inflammation (Phase 1)

Liver Neoplasms (Phase 2)

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 1)

Neuroblastoma (Phase 2)

Neurocognitive Disorders (Phase 1)

Pancreatic Neoplasms (Phase 2)

Peutz-Jeghers Syndrome (Phase 2)

Prostatic Neoplasms (Phase 2)

Smallpox (Phase 1)

Syndrome (Phase 2)

Vaccinia (Phase 1)

Overview

Highest Phase: Phase 4
# of Trials: 44
# of Trial APIs: 53